MORRISVILLE, N.C.--(BUSINESS WIRE)--Centice Corporation®, a pioneer in chemical verification of dispensed drug prescriptions and the manufacturer of the PASS Rx® system, today announced the publication of findings from research into the risk levels of the drug dispensing process. The study was developed for Centice by John M. Kessler, Pharm.D., B.C.P.S., Founder and Chief Clinical Officer of SecondStory Health, L.L.C.
